Zinc is required in pyrrolidine dithiocarbamate inhibition of NF-kappaB activation

FEBS Lett. 1999 Apr 16;449(1):28-32. doi: 10.1016/s0014-5793(99)00390-7.

Abstract

Pyrrolidine dithiocarbamate (PDTC) is a potent inhibitor of nuclear factor kappa B (NF-kappaB) activation. PDTC inhibited basal NF-kappaB activity of endothelial cells. PDTC, however, failed to inhibit basal NF-kappaB activity after withdrawal of serum in the media, and the inhibitory effect of PDTC could be restored by addition of zinc. When various preparations of metal ion-EDTA were tested with PDTC in serum-containing media, only Zn-EDTA failed to block the inhibitory effect of PDTC. The dependence on zinc was also noted in PDTC inhibition of NF-kappaB stimulated by TNF alpha. These facts suggest that zinc is required for PDTC inhibition of NF-kappaB activation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antioxidants / metabolism*
  • Antioxidants / pharmacology
  • Cations
  • Cattle
  • Cells, Cultured
  • Metals
  • NF-kappa B / antagonists & inhibitors*
  • Pyrrolidines / metabolism*
  • Pyrrolidines / pharmacology
  • Thiocarbamates / metabolism*
  • Thiocarbamates / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology
  • Zinc / metabolism*

Substances

  • Antioxidants
  • Cations
  • Metals
  • NF-kappa B
  • Pyrrolidines
  • Thiocarbamates
  • Tumor Necrosis Factor-alpha
  • pyrrolidine dithiocarbamic acid
  • Zinc